Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V J Hruby

Showing results (301-310 of 504) with videos related to

Pageof 51
Sort By:
Bioconjugate Chemistry|May 1, 1997
Peptide targeting and delivery across the blood-brain barrier utilizing synthetic triglyceride esters: design, synthesis, and bioactivityD Patel, B D McKinley, T P Davis, et al.
Biochemistry|December 7, 1993
Comparison of the membrane-bound states of two structurally similar delta-selective opioid peptides by transferred nuclear Overhauser effect spectroscopy and molecular modelingT O Matsunaga, N Collins, V Ramaswami, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestineJ E Fox-Threlkeld, E E Daniel, F Christinck, et al.
Journal of Medicinal Chemistry|September 7, 2001
A new approach to search for the bioactive conformation of glucagon: positional cyclization scanningJ M Ahn, P M Gitu, M Medeiros, et al.
Journal of Medicinal Chemistry|June 21, 1996
Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differencesB Y Azizeh, M D Shenderovich, D Trivedi, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|July 1, 1997
Synthesis and biological properties of beta-MePhe3 analogues of deltorphin I and dermenkephalin: influence of biased chi 1 Phe3 residues on peptide recognition for delta-opioid receptorsA Misicka, S Cavagnero, R Horvath, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|April 1, 1997
Structure-activity studies of hydrophobic amino acid replacements at positions 9, 11 and 16 of glucagonN S Sturm, A M Hutzler, C S David, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
Precision cut tissue slices in culture: a new tool in pharmacologyK Brendel, R L McKee, V J Hruby, et al.
Biochimica Et Biophysica Acta|November 26, 1997
Interaction of a highly potent dimeric enkephalin analog, biphalin, with model membranesM Romanowski, X Zhu, V Ramaswami, et al.
Journal of Medicinal Chemistry|February 26, 2000
Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assaysG G Bonner, P Davis, D Stropova, et al.
Pageof 51

Showing results (301-310 of 504) with videos related to

Sort By:
Pageof 51
Bioconjugate Chemistry|May 1, 1997
Peptide targeting and delivery across the blood-brain barrier utilizing synthetic triglyceride esters: design, synthesis, and bioactivityD Patel, B D McKinley, T P Davis, et al.
Biochemistry|December 7, 1993
Comparison of the membrane-bound states of two structurally similar delta-selective opioid peptides by transferred nuclear Overhauser effect spectroscopy and molecular modelingT O Matsunaga, N Collins, V Ramaswami, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestineJ E Fox-Threlkeld, E E Daniel, F Christinck, et al.
Journal of Medicinal Chemistry|September 7, 2001
A new approach to search for the bioactive conformation of glucagon: positional cyclization scanningJ M Ahn, P M Gitu, M Medeiros, et al.
Journal of Medicinal Chemistry|June 21, 1996
Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differencesB Y Azizeh, M D Shenderovich, D Trivedi, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|July 1, 1997
Synthesis and biological properties of beta-MePhe3 analogues of deltorphin I and dermenkephalin: influence of biased chi 1 Phe3 residues on peptide recognition for delta-opioid receptorsA Misicka, S Cavagnero, R Horvath, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|April 1, 1997
Structure-activity studies of hydrophobic amino acid replacements at positions 9, 11 and 16 of glucagonN S Sturm, A M Hutzler, C S David, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
Precision cut tissue slices in culture: a new tool in pharmacologyK Brendel, R L McKee, V J Hruby, et al.
Biochimica Et Biophysica Acta|November 26, 1997
Interaction of a highly potent dimeric enkephalin analog, biphalin, with model membranesM Romanowski, X Zhu, V Ramaswami, et al.
Journal of Medicinal Chemistry|February 26, 2000
Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assaysG G Bonner, P Davis, D Stropova, et al.
Pageof 51